Oncology – Targeted therapy Class

Selumetinib

Brand: Koselugo (global)
Subclass: MEK inhibitor
PK: t½ 7 hours | Clearance: hepatic
moderate
AE: Diarrhea, acneiform rash, fatigue, cardiomyopathy risk (↓LVEF)